Publication | Closed Access

The farnesyl transferase inhibitor R115777 (Zarnestra®) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa®) and Pamidronate

Molecular PharmacologyMedicinal ChemistryZoledronic AcidChemoprevention StrategyMedicineGrowth InhibitionCancer Cell BiologyCancer GrowthEpidermoid Cancer CellsAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer ResearchDrug Discovery